← Back to Patent Explorer
US4066742A Expired / Lapsed US ⏱️ 0.0 years remaining

Tc-99m sulfur colloid radiopharmaceuticals

Assignee: Medi Physics Inc
•
Filing: 1977-02-14
•
Granted: 1978-01-03
•
Expires: 1997-02-14
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A Tc-99m stannous sulfur colloid radiopharmaceutical having simplicity of formulation, improved stability and desirable small particle size as well as a method of preparation therefor are described. Also provided is a reagent suitable for the preparation of such radiopharmaceutical by the addition thereto of technetium-99m pertechnetate.

Inventors

  • 👤 Michael David Garrett

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-04 18:51
CPC Classifications
A; A61; A61K; A61K51/00; A61K51/12; A61K51/1217; A61K51/02; A61K51/025; A61K2123/00; Y; Y10; Y10S; Y10S516/00; Y10S516/924

Claims Analysis

Total Claims: 9
Claim 1
Independent Claim 146 words
A method for the preparation of a stannous sulfur colloid reagent suitable for the preparation of a size-stabilized Tc-99m-labeled radiopharmaceutical which comprises: a. adding a sufficient quantity of a 1 molar colloid of stannous chloride in sterile, pyrogen-free water to a predetermined quantity of distilled water to achieve a stannous chloride concentration in the final reagent of between about 0.5 and about 2.0 millimoles; b. adding to the mixture of step a) a sufficient quantity of 5% by weight aqueous solution of gelatin to achieve a gelatin concentration in the final reagent of between about 0.05% by weight and about 1.0% by weight; c. treating the mixture of step b) with hydrogen sulfide gas; d. purging the reagent formed in c) with nitrogen gas; e. filtering said reagent through a filter having openings of 0.45 micron; and f. aseptically sealing said reagent in a nitrogen-purged ampul.
Claim 2
Independent Claim 146 words
A method for the preparation of a stannous sulfur colloid reagent suitable for the preparation of a size-stabilized Tc-99m-labeled radiopharmaceutical which comprises: a. adding a sufficient quantity of a 1 molar colloid of stannous chloride in sterile, pyrogen-free water to a predetermined quantity of distilled water to achieve a stannous chloride concentration in the final reagent of between about 0.5 and about 2.0 millimoles; b. adding to the mixture of step a) a sufficient quantity of 5% by weight aqueous solution of gelatin to achieve a gelatin concentration in the final reagent of between about 0.05% by weight and about 1.0% by weight; c. treating the mixture of step b) with hydrogen sulfide gas; d. purging the reagent formed in c) with nitrogen gas; e. filtering said reagent through a filter having openings of 0.45 micron; and f. aseptically sealing said reagent in a nitrogen-purged ampul.
Claim 3
Dependent Claim 55 words
A method in accordance with claim 1 wherein the amount of said colloid of stannous chloride added is sufficient to achieve a stannous chloride concentration in the final reagent of about 1.0 millimole and the amount of said gelatin solution added is sufficient to achieve a concentration of 0.2% by weight in the final reagent.
Claim 4
Dependent Claim 40 words
A packaged reagent for preparing size-stabilized sulfur colloid consisting of an aqueous colloid of stannous sulfide additionally containing from about 0.05% by weight to about 1.0% by weight gelatin, based on the total reagent, aseptically enclosed in a nitrogen-purged ampule.
Claim 5
Dependent Claim 40 words
A packaged reagent for preparing size-stabilized sulfur colloid consisting of an aqueous colloid of stannous sulfide additionally containing from about 0.05% by weight to about 1.0% by weight gelatin, based on the total reagent, aseptically enclosed in a nitrogen-purged ampule.
Claim 6
Dependent Claim 23 words
A reagent in accordance with claim 3 wherein the concentration of said stannous sulfide is between from about 0.5 to about 2.0 millimoles.
Claim 7
Dependent Claim 28 words
A reagent in accordance with claim 3 wherein the concentration of said stannous sulfide is about 1 millimolar and the concentration of gelatin is about 0.2% by weight.
Claim 8
Dependent Claim 11 words
A radiopharmaceutical comprising the reagent of claim 3 labeled with technetium-99m.
Claim 9
Dependent Claim 30 words
A method of imaging the liver and spleen of a patient comprising intravenously injecting the patient with the radiopharmaceutical of claim 6 and then scintigraphically imaging the liver and spleen.

References Cited (Backward Citations)

US3720761A Cited
US3683066A Cited
US3736262A Cited
US3803299A Cited
US3862299A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1981-01-02 1981-07-04 1982-01-03 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1985-01-02 1985-07-04 1986-01-03 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1989-01-02 1989-07-04 1990-01-03 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag